Heart News and Research

RSS

CCG announces acquisition of Bakersfield Heart Hospital

The Cardiovascular Care Group (CCG) today announced it has finalized the acquisition of a majority interest in the Bakersfield (California) Heart Hospital from MedCath Corporation.

2 Jul 2012

Deleting a single gene results in autism-like behavior

Deleting a single gene in the cerebellum of mice can cause key autistic-like symptoms, researchers have found. They also discovered that rapamycin, a commonly used immunosuppressant drug, prevented these symptoms.

2 Jul 2012

'Adaptive' clinical trials now being planned at U-M, other sites

A new approach to testing medical treatment options could ensure that more patients get the most beneficial treatment for them - but still yield valuable research results that stand up to scientific scrutiny.

2 Jul 2012

Platelet activation linked to osteoporosis

Elderly, postmenopausal women with osteoporosis have elevated platelet volumes, report researchers.

2 Jul 2012

Folic acid ‘may benefit diabetics’

Folic acid supplementation can significantly reduce homocysteine levels and may therefore offer an approach for lowering cardiovascular risk among patients with Type 2 diabetes, report researchers.

2 Jul 2012

Shots to the heart ‘not risky’

Taser deployments to the chest are no more dangerous than those to other body parts, say researchers.

2 Jul 2012

Hearing loss linked to Alzheimer's, heart disease, chronic kidney diseases and diabetes

Ear plug retailer, All Ear Plugs, urges Brits to take more care in protecting their ears following the release of data from the Better Hearing Institute (BHI) in the US linking hearing loss to chronic diseases.

2 Jul 2012

Current diagnosis and treatment approaches for rheumatoid arthritis

In the realm of deadly and disabling diseases, conditions such as cancer and Alzheimer's seem to attract the most media attention. But there are others that take a similarly high toll, and rheumatoid arthritis is one of them, Mayo Clinic researchers say. It is a common cause of disability: 1 of every 5 rheumatoid arthritis patients is unable to work two years after diagnosis, and within five years, that rises to one-third. Life expectancy drops by up to five years.

2 Jul 2012

Pediatric pain still common in hospitals

Despite advances in the understanding and treatment of pediatric pain, many hospitalized children continue to experience serious pain, according to a Johns Hopkins Children’s Center study published online ahead of print in the journal Pain Management Nursing.

2 Jul 2012

Study illuminates key step in the journey of inflammation-producing immune cells

Like detectives seeking footprints and other clues on a television "whodunit," science can also benefit from analyzing the tracks of important players in the body's molecular landscape. Klaus Ley, M.D., a scientist at the La Jolla Institute for Allergy & Immunology, has done just that and illuminated a key step in the journey of inflammation-producing immune cells.

2 Jul 2012

Textile cooling pads to prevent neurological damage after successful resuscitation

Textile cooling pads are to be used in future to prevent neurological damage after successful resuscitation. The system developed by scientists from the Hohenstein Institute in Bönnigheim requires no electric power, making it ideal especially for first aid in case of cardiac arrest.

30 Jun 2012

Immediately after the Decision: Confusion

Because two cable TV networks initially were wrong in their reports about the court's verdict, lawmakers, candidates and even the president were confused about the court's findings.

30 Jun 2012

Roberts' position dismays conservatives, surprises President who once opposed his confirmation

The chief justice treads a very narrow path to find the health law constitutional and helps to redefine the public's view of the court.

30 Jun 2012

GOP leaders react to ruling by renewing pledges to repeal the health law

From Republican presidential hopeful Mitt Romney to key House and Senate leaders, the call to repeal the sweeping health overhaul came loud and clear in the wake of the Supreme Court's decision largely upholding it.

29 Jun 2012

Setting the scene: The Supreme Court's health law ruling

With a ruling expected soon after the justices take the bench at 10 a.m., speculation focuses not only on what its various elements will be, but how the various players will spin them.

29 Jun 2012

Taser shots to the chest are no more dangerous: Study

Taser shots to the chest are no more dangerous than those delivered to other body locations, according to a new study by one of the country's leading experts on the devices.

29 Jun 2012

New drug for Type 2 diabetes results in less hypoglycaemia, less weight gain and perhaps less cardiovascular risk for patients

A new drug could offer significant advantages over existing treatments for Type 2 diabetes patients who don’t respond to metformin, the most commonly prescribed initial drug treatment for the disease. The new drug, linagliptin, results in significantly less weight gain than the most common second-line treatments currently used, and may even carry a smaller risk of cardiovascular events such as heart attack and stroke, according to an Article published Online First in The Lancet.

29 Jun 2012

Novo Nordisk, BRI collaborate to speed-up translational research of autoimmune diseases

Benaroya Research Institute at Virginia Mason (BRI), a non-profit biomedical research institute in Seattle, Wash., and Novo Nordisk, a global health care company headquartered in Denmark, today announced a three-year collaborative agreement to potentially speed-up translational research of the diagnosis and treatment of rheumatoid arthritis, inflammatory bowel disease and lupus.

29 Jun 2012

Scientists use new method to assemble massive catalogue of data on proteins

Scientists at the Novo Nordisk Foundation Center for Protein Research at the University of Copenhagen have used a new method to assemble a massive catalogue of data on proteins. This gives them unprecedented insight into a process called protein phosphorylation.

29 Jun 2012

Astellas Pharma receives FDA approval for Myrbetriq to treat overactive bladder

The U.S. Food and Drug Administration today approved Myrbetriq (mirabegron) to treat adults with overactive bladder, a condition in which the bladder muscle cannot be controlled, squeezes too often or squeezes without warning.

29 Jun 2012